ScholarIQanswers from OpenAlex

<i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model

PaperCitations, authors & open-access status

<i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model is a paper indexed in ScholarIQ from OpenAlex.

How many citations does <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model have?

ScholarIQcitation count

<i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model has 70 citations in the OpenAlex counts ScholarIQ stores.

When was <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model published?

ScholarIQyear

<i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model has 2021 year in the ScholarIQ index.

What is the open-access status of <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model?

ScholarIQoa status

<i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model has gold oa status in the ScholarIQ index.

What is the DOI of <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model?

ScholarIQdoi

The DOI for <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model is on the source record.

What is the PMID of <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model?

ScholarIQpmid

The PMID for <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model is on the source record.

What is the OpenAlex record for <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model?

ScholarIQopenalex

The OpenAlex for <i>Tet2</i> deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial